Detalhe da pesquisa
1.
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
Mult Scler
; 28(10): 1591-1605, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35380078
2.
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
Mult Scler
; 28(10): 1526-1540, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35261318
3.
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Mult Scler
; 27(14): 2219-2231, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33769117
4.
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Mult Scler
; 27(10): 1564-1576, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33205682
5.
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.
J Med Internet Res
; 23(10): e29558, 2021 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34612826
6.
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study.
J Med Internet Res
; 22(2): e16932, 2020 02 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32049062
7.
Learning ability correlates with brain atrophy and disability progression in RRMS.
J Neurol Neurosurg Psychiatry
; 90(1): 38-43, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30322898
8.
Predicting risk of secondary progression in multiple sclerosis: A nomogram.
Mult Scler
; 25(8): 1102-1112, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29911467
9.
Cutaneous Tumors in Swiss Dogs: Retrospective Data From the Swiss Canine Cancer Registry, 2008-2013.
Vet Pathol
; 55(6): 809-820, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30131007
10.
Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Int J Cancer
; 140(7): 1680-1692, 2017 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27943293
11.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Mult Scler
; 23(5): 656-664, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27411701
12.
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
Mult Scler
; 22(10): 1297-305, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26585439
13.
Incidence rates of the most common canine tumors based on data from the Swiss Canine Cancer Registry (2008 to 2020).
PLoS One
; 19(4): e0302231, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38635572
14.
Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones.
Eur J Nutr
; 52(2): 625-35, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22573211
15.
Epithelial membrane antigen-reactive feline chordoid meningioma in a European wildcat (Felis silvestris).
J Comp Pathol
; 201: 114-117, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36791602
16.
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue.
Neoplasia
; 35: 100858, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36508875
17.
The effect of disease modifying therapies on fatigue in multiple sclerosis.
Mult Scler Relat Disord
; 79: 105065, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37839365
18.
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.
J Interferon Cytokine Res
; 43(6): 246-256, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36454249
19.
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
J Neurol
; 269(9): 5093-5104, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35639197
20.
Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma.
Cancer Med
; 10(1): 286-296, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33179858